![](https://www.forbes.com.au/wp-content/uploads/2023/10/image-29.png?w=960)
This startup raised $30 million to take on Microsoft’s AI notetaker for doctors
The Series B round led by Spark Capital values 5-year old Abridge, which is used by 5,000 doctors, at $200 million. But it’s up against Nuance, which Microsoft bought for $18.8 billion and is used by half a million doctors.